Agenda Topics- Adult Stem Cells for Cellular Therapy
- Bone Marrow vs. Adipose-derived Stem Cells
- Clinical Practicum: Real-Time Demonstration of the use of Adipose-Derived Stem Cells
- Current State of the Science: Technical Accomplishments and Hurdles Ahead
- Regulatory Trends Worldwide
- Research vs. Clinical Challenges in Stem Cell Translation
- The Route for Clinical Translation of Stem Cells: The Path to Commercialization
- Wound Healing and Cartilage Replacement: Research and Clinical Trends
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to date , , David Angeloni, President, Millennium Medical Technologies (MMT) Mark Berman, Past President, American Academy of Cosmetic Surgery; Medical Director, California Stem Cell Treatment Center Mel Bircoll, Surgeon, California Academy of Cosmetic Surgery Lee Buckler, Vice President , RepliCel Life Sciences Dennis Clegg, Professor, University of California Santa Barbara Mo Dao, Senior Scientist, Sanbio John Feller, Medical Director, Desert Medical Imaging Fred Fox, Ethicist, BioMedical Research Institute -- BioMed IRB Akiko Futamura, President and Chief Executive Officer, InfiniteBio Albert Lai, Chief Medical Officer, Centers of Rehabilitation and Pain Medicine Robert Mays, Senior Director, Athersys Inc Wade McKenna, President & Founder, Mckenna Orthopaedics, North Central Texas Orthopeadic Surgery and Sports Medicine David Morrow, Founder, The Morrow Institute Gary Oosta, Strategic Technology Assessment Analyst, Allan Wu, Chief Scientific Officer, The Morrow Institute
|